Induction of primate TH2 lymphokines to suppress TH1 cells.
Smit
J A
JA
Department of Surgery, University of the Witwatersrand Medical School, Johannesburg, South Africa.
Stark
J H
JH
Myburgh
J A
JA
D000818:Animals; D002478:Cells, Cultured; D002772:Cholera Toxin / Q000494:pharmacology; D005576:Colforsin / Q000494:pharmacology; D004789:Enzyme Activation; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007376:Interleukin-2 / Q000096:biosynthesis; D015847:Interleukin-4 / Q000096:biosynthesis; D015759:Ionomycin / Q000494:pharmacology; D008222:Lymphokines / Q000096:biosynthesis*; D010215:Papio; D011493:Protein Kinase C / Q000378:metabolism; D016559:Tacrolimus / Q000494:pharmacology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology*; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology*; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D007166:Immunosuppressive Agents; D007376:Interleukin-2; D008222:Lymphokines; D010566:Virulence Factors, Bordetella; D005576:Colforsin; D015847:Interleukin-4; D015759:Ionomycin; D002772:Cholera Toxin; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate; D016559:Tacrolimus